Response to "Three drugs are unnecessary for treating paucibacillary leprosy-A critique of the WHO guidelines"

PLoS Negl Trop Dis. 2020 Jun 4;14(6):e0008169. doi: 10.1371/journal.pntd.0008169. eCollection 2020 Jun.

Authors

Bhushan Kumar¹, Vishal Thakur², Tarun Narang², Sunil Dogra²

Affiliations

¹ Consultant Dermatologist Shalby Hospital, SAS Nagar, Punjab.
² Department of Dermatology, Venereology, and Leprology; Postgraduate Institute of Medical Education and Research, Chandigarh, India.

No abstract available

Publication types

Comment

MeSH terms

Drug Therapy, Combination
Humans
Leprosy, Paucibacillary*

Grants and funding

The author(s) received no specific funding for this work.